Peripheral antihyperalgesic and analgesic actions of ketamine and amitriptyline in a model of mild thermal injury in the rat

Anesthesia and Analgesia

Volumn 97, Issue 1, 2003, Pages 168-173

  Oatway, Mark ^a   Reid, Allison ^a   Sawynok, Jana ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; KETAMINE;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOSE TIME EFFECT RELATION; DRUG MECHANISM; EXPERIMENTAL MODEL; FOOT PAD; HYPOALGESIA; MALE; NONHUMAN; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; RAT; SENSITIZATION; THERMAL INJURY;

EID: 0037974372     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000067406.52093.BF     Document Type: Article

References (43)

1. Fisher K, Coderre TJ, Hagen NA. Targeting the N-methyl-D-aspartate receptor for chronic pain management: preclinical animal studies, recent clinical experience and future research directions. J Pain Symptom Manage 2000;20:358-73.
2. Sindrup SH, Jensen TS. Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain 1999;83:389-400.
3. Hirota K, Lambert DG. Ketamine: its mechanism(s) of action and unusual clinical uses. Br J Anaesth 1996;77:441-4.
4. Meller ST. Ketamine: relief from chronic pain through actions at the NMDA receptor? Pain 1996;68:435-6.
5. Sindrup SH. Antidepressants as analgesics. In: Yaksh TL, Maze M, Lynch C, et al., eds. Anesthesia: biologic foundations. Philadelphia: Lippincott-Raven, 1997:987-97.
6. Davidson EM, Carlton SM. Intraplantar injection of dextrorphan, ketamine or memantine attenuates formalin-induced behaviors. Brain Res 1998;785:136-42.
7. Sawynok J, Reid AR. Modulation of formalin-induced behaviors and edema by local and systemic administration of dextro-methorphan, memantine and ketamine. Eur J Pharmacol 2002; 450:153-62.
8. Sawynok J, Reid AR, Esser MJ. Peripheral antinociceptive action of amitriptyline in the rat formalin test: involvement of adenosine. Pain 1999;80:45-55.
9. Esser MJ, Sawynok J. Acute amitriptyline in a rat model of neuropathic pain: differential symptom and route effects. Pain 1999;80:643-53.
10. Khan MA, Gerner P, Wang GK. Amitriptyline for prolonged cutaneous analgesia in the rat. Anesthesiology 2002;96:109-16.
11. Crowley KL. Clinical application of ketamine ointment in the treatment of sympathetically maintained pain. Int J Pharm Compound 1998;2:122-7.
12. Wood R. Ketamine for pain in hospice patients. Int J Pharm Compound 2000;4:258-9.
13. McCleane GJ. Topical doxepin hydrochloride reduces neuropathic pain: a randomized, double-blind, placebo controlled study. Pain Clin 2000;12:47-50.
14. McCleane GJ. Topical application of doxepin hydrochloride, capsaicin and a combination of both produces analgesia in chronic human neuropathic pain: a randomized, double-blind, placebo-controlled study. Br J Clin Pharmacol 2000;49:574-9.
15. Raja SN, Campbell JN, Meyer RA. Evidence for different mechanisms of primary and secondary hyperalgesia following heat injury to the glabrous skin. Brain 1984;107:1179-88.
16. Warnke T, Jorum E, Stubhaug A. Local treatment with the N-methyl-D-aspartate receptor antagonist ketamine, inhibits development of secondary hyperalgesia in man by a peripheral action. Neurosci Lett 1997;227:1-4.
17. Pedersen JL, Galle TS, Kehlet H. Peripheral analgesic effects of ketamine in acute inflammatory pain. Anesthesiology 1998;89: 58-66.
18. Nozaki-Taguchi N, Yaksh TL. A novel model of primary and secondary hyperalgesic after mild thermal injury in the rat. Neurosci Lett 1998;254:25-8.
19. Nozaki-Taguchi N, Yaksh TL. Characterization of the antihyperalgesic action of a novel peripheral mu-opioid receptor agonist: loperamide. Anesthesiology 1999;90:225-34.
20. Sawynok J, Esser MJ, Reid AR. Peripheral antinociceptive actions of desipramine and fluoxetine in an inflammatory and neuropathic pain test in the rat. Pain 1999;82:149-58.
21. Hargreaves K, Dubner R, Brown F, et al. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 1998;32:77-88.
22. Jun JH, Yaksh TL. The effect of intrathecal gabapentin and 3-isobutyl γ-aminobutyric acid on the hyperalgesia observed after thermal injury in the rat. Anesth Analg 1998;86:348-54.
23. Treede RD, Meyer RA, Raja SN, Campbell JN. Peripheral and central mechanisms of cutaneous hyperalgesia. Prog Neurobiol 1992;38:397-421.
24. Levine JD, Fields HL, Basbaum AI. Peptides and the primary afferent nociceptor. J Neurosci 1993;13:2273-86.
25. + current in nociceptors. Proc Natl Acad Sci U S A 1996;93:1108-12.
26. Andreev N, Urban L, Dray A. Opioids suppress spontaneous activity of polymodal nociceptors in rat paw skin induced by ultraviolet irradiation. Neuroscience 1994;58:793-8.
27. Zhou L, Zhang Q, Stein C, Schäfer M. Contribution of opioid receptors on primary afferent versus sympathetic neurons to peripheral opioid analgesia. J Pharmacol Exp Ther 1998;286: 1000-6.
28. Omote K, Kawamata T, Kawamata M, Namiki A. Formalin-induced release of excitatory amino acids in the skin of the rat hindpaw. Brain Res 1998;787:161-4.
29. Carlton SM, Coggeshall RE. Inflammation-induced changes in peripheral glutamate receptor populations. Brain Res 1999;820: 63-70.
30. Du J, Koltzenburg M, Carlton SM. Glutamate-induced excitation and sensitization of nociceptors in rat glabrous skin. Pain 2001; 89:187-98.
31. Carlton SM. Peripheral excitatory amino acids. Curr Opin Pharmacol 2001;1:52-6.
32. Reynolds IJ, Miller RJ. Tricyclic antidepressants block N-methyl-D-aspartate receptors: similarities to the action of zinc. Br J Pharmacol 1988;95:95-102.
33. 2+ levels in neuronal culture. Eur J Pharmacol 1992; 219:53-7.
34. Frenkel C, Urban BW. Molecular actions of racemic ketamine on human CNS sodium channels. Br J Anaesth 1992;69:292-7.
35. Bräu ME, Sander F, Vogel W, Hempelmann G. Blocking mechanisms of ketamine and its enantiomers in enzymatically demyelinated peripheral nerve as revealed by single-channel experiments. Anesthesiology 1997;86:394-404.
36. + channels by antidepressant drugs. J Pharmacol Exp Ther 1998;284:208-14.
37. + channels in rat dorsal root ganglion neurons. Eur J Pharmacol 2000;401:297-305.
38. + current in rat sensory neurons in vitro. Neurosci Lett 1996;212:83-6.
39. Sawynok J, Esser MJ, Reid AR. Antidepressants as analgesics: an overview of central and peripheral mechanisms of action. J Psychiatry Neurosci 2001;26:21-8.
40. Blier P, Abbott FV. Putative mechanisms of action of antidepressant drugs in affective and anxiety disorders and pain. J Psychiatry Neurosci 2001;26:37-43.
41. Richelson E, Pfenning M. Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: most antidepressants selectively block norepinephrine uptake. Eur J Pharmacol 1984;104:277-86.
42. Hall H, Ögren SO. Effects of antidepressant drugs on different receptors in the brain. Eur J Pharmacol 1981;70:393-407.
43. Guo Y, Mochizuki T, Morii E, et al. Role of mast cell histamine in the formation of rat paw edema: a microdialysis study. Eur J Pharmacol 1997;331:237-43.